The University of Medicine and Pharmacy "Iuliu Hatieganu" in Cluj-Napoca (UMFCN) is one of the fastest growing medical universities in the field of research, with a long history of medical education (since the 16th century) and modernity, focused on a wide range of research topics, such as: a) systems biology; b) nanomedicine; c) cancer, immunology and aging; d) structural and functional genomics; e) translational research; f) biotechnology; molecular chemistry and pharmacy; g) stem cells and regenerative medicine; h) public and environmental health.
It offers a very broad modular offer of continuing education in the medical sector, particularly in the areas of quality and risk management, which will be involved in the project.
Its strategic policy allowed it to become the first medical university in Romania.
In recent years, UMFCN has participated in numerous research and development projects, some of which have already been completed, others are under implementation (in 2019 alone, 47 projects are under implementation), through three main sources of funding: from the state budget-32 national projects worth 5,210.690 euros; structural funds - 8 projects worth 11,773,526 euros; European research programs - 9 projects under the Horizon 2020 framework program totaling 2,464,205 euros.
More than 880 UMF employees are involved in research activities, and there is an effective administrative building designed to support and coordinate research activities.